|
Curcumin98™ NEW & IMPROVED FORMULA
Now contains 200x500mg strength capsules with Bioperine for more than
double the absorption. Stimulates Glutathione, helps resolve eye problems,
and is an anti-inflammatory, antibacterial, anti-viral, anti-fungal
etc.
Turmeric has long been revered
for health. In India's system of Ayurvedic medicine, it has been
recognized for thousands of years as a key balancing and detoxifying
herb and is considered to be one of the very best all-around herbs for
general well-being. Curcumin is the main biologically active
part of Turmeric, which only contains 4% curcumin; whereas Curcumin98™
contains 98%.
(please
read this important notice concerning supplement medical claims)
Over
500 references to articles on turmeric and curcumin have been published
in peer reviewed professional journals.
It has
been identified in pharmacology as:
-
antibacterial
-
antiviral
-
anti fungal
-
anti yeast
-
antiallergenic
-
anti- inflammatory
-
anti- oxidant
-
anti- spasmodic
-
carminative
-
diuretic
-
anti-tumour
Turmeric
and Curcumin have traditionally been used to support those suffering
from pain and inflammation and may help
symptoms of:
acne
allergies
auto-immune disorders
burns
chicken pox
diabetes
digestive disorders
gallbladder problems
liver
damage
liver disorders
skin rashes
ulcers
eye problems such as cataracts.
(read study below)
If that is not enough,
Turmeric has been used for thousands of years by Indian Women to make
their skin beautiful and blemish free.
No side effects have been found taking
high doses of Curcumin; rare cases of stomach upset or diarrhoea may
be resolved by temporarily reducing the dosage and taking with food.
Curcumin Treating eye disorders
Curcumin is apparently more than your
typical kitchen spice. It's the substance that gives ginger its yellowish
colour, and it has been implicated in the treatment of certain eye diseases
and conditions. One of those is known as chronic anterior uveitis (CAU),
an inflammatory condition of the vascular layer of the eye, particularly
the area comprising the iris. In one small study, Curcumin was given
orally to 32 chronic anterior uveitis patients who were divided into
two groups. The first group received Curcumin alone, whereas the second
group received a combination of Curcumin and antitubercular treatment.
Amazingly, all of the patients treated with Curcumin alone improved,
compared to a response rate of 86% among those receiving the combination
therapy. The researchers concluded that Curcumin was just as effective
as corticosteroid therapy, the only available standard treatment for
chronic anterior uveitis at present, adding that "the lack of side effects
with Curcumin is its greatest advantage compared with corticosteroids."
Similar research using rats and rabbits
found that Curcumin effectively inhibited chemically induced cataract
formation, even at very low dietary levels. The same study also found,
for the first time, that this type of induced cataract may be accompanied
by apoptosis of epithelial cells in the eye and that Curcumin may lessen
the apoptotic effect. In one of the earliest studies examining Curcumin
as a potential cataract therapy, researchers fed two groups of rats,
diets that included corn oil, or a combination of Curcumin and corn
oil for 14 days. Afterward, their lenses were removed and examined for
the presence of lipid peroxidation. The scientists discovered that "the
lenses from Curcumin-treated rats were much more resistant to induced
opacification than were lenses from control animals."
Research Studies
Awasthi S et al. Curcumin protects
against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat
lenses. Am J Clin Nutr 1996 Nov;64 (5):761-6.
Lal B et al. Efficacy of curcumin in the management of chronic anterior
uveitis. Phytother Res 1999 Jun;13(4):318-22.
Pandya U et al. Dietary curcumin prevents ocular toxicity of naphthalene
in rats. Toxicol Lett 2000 Jun 5;115(3):195-204.
Curcumin may
block the progression of Multiple Sclerosis (MS)
NEW ORLEANS
(Reuters Health)
-
Preliminary studies
in rats suggest that curcumin, a compound found in the curry spice turmeric,
may block the progression of multiple sclerosis (MS).
According to researcher
Dr. Chandramohan Natarajan of Vanderbilt University in Nashville, Tennessee,
rats with an MS-like illness showed little or no signs of disease symptoms
after being injected with curcumin, while animals without the treatment
went on to severe paralysis.
"We
got a very good inhibition of the disease by treating with curcumin,"
Natarajan told Reuters Health. He presented the findings here Tuesday
at the annual Experimental Biology 2002 conference.
No one knows what
causes multiple sclerosis, in which the body's immune system attacks
the protective myelin sheath surrounding nerve fibres in the brain and
spine. Symptoms of multiple sclerosis include muscle weakness and stiffness,
balance and coordination problems, numbness and vision disturbances.
Interest in the potential neuroprotective
properties of curcumin rose after studies found very low levels of neurological
diseases such as Alzheimer's in elderly Indian populations. Added to
this were studies confirming curcumin as a potent anti-inflammatory
agent, effective in wound healing. And just last fall, researchers at
the University
of California,
Los Angeles
reported that curcumin appeared to slow the progression of Alzheimer's
in mice.
In their 30-day
study, Natarajan and co-researcher Dr. John Bright gave injections of
50- and 100-microgram doses of curcumin, three times per week, to a
group of mice bred to develop a disease called experimental autoimmune
encephalomyelitis (EAE)--an autoimmune condition used by researchers
as a model for multiple sclerosis because it also results in the slow
erosion of myelin. They then watched the rats for signs of MS-like neurological
impairment.
By day 15, rats
who had not received curcumin developed EAE to such an extent that they
displayed complete paralysis of both hind limbs, according to Natarajan.
In contrast, rats
given the 50-microgram dose of the curry compound showed only minor
symptoms, such as a temporarily stiff tail. And rats given the 100-microgram
dose appeared completely unimpaired throughout the 30 days of the study.
The results didn't
really surprise Natarajan. "In Asian countries, such as India, China,
who are eating more spicy foods, more yellow compounds like curcumin...there
are only very, very rare reports of MS," he pointed out. He said the
doses the rats received were roughly equivalent in human terms to those
found in a typical Indian diet.
Just how curcumin might work to thwart
the progression of demyelinisation remains unclear. But the
Nashville
researchers believe it may interrupt the production of IL-12, a protein
that plays a key role in signalling immune cells to launch their assault
on the myelin sheath.
Natarajan stressed
that "we have to do a lot of work on this," including examining other
potential mechanisms by which curcumin slows EAE and, potentially, MS.
The work remains preliminary, and MS patients
should follow their doctor's advice when it comes to treating the disease.
Still, Natarajan said adding a little curry to the diet couldn't hurt.
"I think using this spice in their food could be of help," he said.
Curcumin, the active ingredient in the herb turmeric, is being investigated
for use in Alzheimer's disease due to its potent anti-inflammatory action
(Joe 1997; Grilli 1999)
Curcumin
has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils
in vitro.
Ono K, Hasegawa K, Naiki H, Yamada M. J Neurosci Res.
2004 Mar 15;75(6):742-50.
Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.
|
Recommended
use: